GENTIBIO, INC.
Biotech · Private
Allogeneic engineered regulatory T cells (EngTregs) overexpressing ST2 for stroke recovery
- Grants
- $1.2M
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 0 granted · 40 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Development of Tissue Engineered Tregs as a Treatment for Acute Ischemic Stroke | $1,150,417 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1098 | DARK MATTER THERAPEUTICS, INC. | — | — |
| 1099 | UFORCE BIOTECHNOLOGY, LLC | — | — |
| 1100 | PICCOLO BIOSYSTEMS, INC. | — | — |
| 1101 | GENTIBIO, INC. | — | — |
| 1102 | LUXBIOME INC | — | — |
| 1103 | Pattern Pharma Inc. | — | $1.2M |
| 1104 | ANCHORCHEM LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Compositions And Methods For Engineering Treg Cells For Treatment Of Diabetesapplication
- Compositions And Methods For Engineering Stable Tregsapplication
- Compositions And Methods For Controlling Cell Signaling With Chimeric Receptorsapplication
- CD19 Car T Regulatory Cellsapplication
- Membrane-anchored Nk Cell Inhibitory Receptor Engagersapplication
- Membrane-anchored Nk Cell Inhibitory Receptor Engagersapplication
- Regulatory T Cells Expressing Chimeric Antigen Receptorsapplication
- Membrane-anchored Nk Cell Inhibitory Receptor Engagersapplication
- Membrane-anchored Nk Cell Inhibitory Receptor Engagersapplication
- CD19 Car T Regulatory Cellsapplication
- CD19 Car T Regulatory Cellsapplication
- CD19 Car T Regulatory Cellsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.